Oskar Hansson
Lunds Universitet
H-index: 122
Europe-Sweden
Top articles of Oskar Hansson
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings | Brain | Hannah Baumeister Jacob W Vogel Philip S Insel Luca Kleineidam Steffen Wolfsgruber | 2024/4/24 |
MRI-Derived AD Signature of Cortical Thinning and Plasma P-Tau217 for Predicting Alzheimer Dementia Among Community-Dwelling Older Adults | Neurology: Clinical Practice | Lei Yu Tianhao Wang Oskar Hansson Shorena Janelidze Melissa Lamar | 2024/6 |
1978 Donanemab in early symptomatic Alzheimer’s Disease: Efficacy and safety in TRAILBLAZER-ALZ 2, Phase 3 Randomized Clinical Trial | Age and Ageing | M Mintun C Ritchie P Solomon JR Sims S Salloway | 2024/1 |
Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease | Annals of neurology | Lukai Zheng Anna Rubinski Jannis Denecke Ying Luan Ruben Smith | 2024/2 |
The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer’s disease patients and AppNL−F/NL−F mice | Alzheimer's Research & Therapy | Cristina Nuñez-Diaz Emelie Andersson Nina Schultz Dovilė Pocevičiūtė Oskar Hansson | 2024/1/2 |
The Relationship between p-tau217, p-tau231, and p-tau205 in the Human Brain Is Affected by the Cellular Environment and Alzheimer’s Disease Pathology | Cells | Malin Wennström Nina Schultz Paula Mille Gallardo Netherlands Brain Bank Geidy E Serrano | 2024/2/11 |
Validation, Deployment, and Real-World Implementation of a Modular Toolbox for Alzheimer’s Disease Detection and Dementia Risk Reduction: The AD-RIDDLE Project | The Journal of Prevention of Alzheimer's Disease | K Malzbender P Barbarino P Barkman Ferrell A Bradshaw AJ Brookes | 2024/3 |
Is GBA1 T369M not a risk factor for Parkinson's disease in the Swedish population? | D Backstrom J Wallenius Z Gan-Or A Puschmann O Hansson | 2024/3/16 | |
Baseline Characteristics from Evoke and Evoke+: Two Phase 3 Randomized Placebo-controlled Trials of Oral Semaglutide in Patients with Early Alzheimer’s Disease (P11-9.013) | Philip Scheltens Alireza Atri Howard Feldman Oskar Hansson Filip Knop | 2024/4/14 | |
Fixel-based analysis reveals tau-related white matter changes in early stages of Alzheimer's disease | Journal of Neuroscience | Khazar Ahmadi Joana B Pereira Danielle van Westen Ofer Pasternak Fan Zhang | 2024/5/1 |
Remote and unsupervised digital memory assessments can reliably detect cognitive impairment in Alzheimer's disease | medRxiv | David Berron Emil Olsson Felix Andersson Shorena Janelidze Pontus Tideman | 2024 |
Translational control of microglial inflammatory and neurodegenerative responses | bioRxiv | Sara Bermudez Junghyun Choi Jacob W Vogel Sunghoon Kim Niaz Mahmood | 2024 |
Effects of certain pre-analytical factors on the performance of plasma phospho-tau217 | Alzheimer's Research & Therapy | Divya Bali Oskar Hansson Shorena Janelidze | 2024/12 |
Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort | Journal of Neurology | Augusto J Mendes Federica Ribaldi Aurelien Lathuiliere Nicholas J Ashton Shorena Janelidze | 2024/1/9 |
Diffusion MRI tracks cortical microstructural changes during the early stages of Alzheimer’s disease | Brain | Nicola Spotorno Olof Strandberg Erik Stomrud Shorena Janelidze Kaj Blennow | 2024/3 |
A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings | Nature Communications | Wagner S Brum Nicholas C Cullen Joseph Therriault Shorena Janelidze Nesrine Rahmouni | 2024/3/14 |
Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration | Rowan Saloner Adam Staffaroni Eric Dammer Erik CB Johnson Emily Paolillo | 2024/3/28 | |
Cerebrospinal fluid reference proteins increase accuracy and interpretability of biomarkers for brain diseases | bioRxiv | Linda Karlsson Jacob Vogel Ida Arvidsson Kalle Åström Shorena Janelidze | 2023 |
Plasma biomarker strategy for selecting patients with Alzheimer disease for antiamyloid Immunotherapies | JAMA neurology | Niklas Mattsson-Carlgren Lyduine E Collij Erik Stomrud Alexa Pichet Binette Rik Ossenkoppele | 2024/1/1 |
Associations between structural brain changes and blood neurofilament light chain protein in treatment-resistant schizophrenia | medRxiv | Brandon-Joe Cilia Dhamidhu Eratne Cassandra Wannan Charles Malpas Shorena Janelidze | 2024 |
Co-Authors
